
Galaxystar Pharma Private Limited
Pharmaceutical trading and manufacturing of medical and chemical products, surgical and scientific apparatus.
Pharmaceutical trading and manufacturing of medical and chemical products, surgical and scientific apparatus.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U51909MH2011PTC214896
214896
Private Limited Indian Non-Government Company
17 Mar 2011
30 Sep 2022
31 Mar 2022
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manoj Sanghani ![]() | Director | 17-Mar-2011 | Current |
Vikramaditya Ambre ![]() | Director | 17-Mar-2011 | Current |
Galaxystar Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 27.43% increase. The company also saw a substantial improvement in profitability, with a 69.48% increase in profit. The company's net worth dipped by a decrease of 2.33%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2021, Galaxystar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Vikramaditya Ambre is a mutual person
Vikramaditya Ambre is a mutual person
₹0
₹10.50 Cr
Date | Lender | Amount | Status |
---|---|---|---|
31 Dec 2014 | Others | ₹6.50 Cr | Satisfied |
04 Nov 2011 | Thane Bharat Sahakari Bank Limited | ₹4.00 Cr | Satisfied |
Unlock and access historical data on people associated with Galaxystar Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galaxystar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxystar Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Galaxystar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Galaxystar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.
A charge registered on 31 Dec 2014 via Charge ID 10558281 with Others was fully satisfied on 18 Jul 2019.
A charge with Others of Rs. 6.50 Cr registered on 31 Dec 2014 with Charge ID 10558281 was modified on 26 Sep 2017.
A charge registered on 04 Nov 2011 via Charge ID 10320630 with Thane Bharat Sahakari Bank Limited was fully satisfied on 20 Apr 2015.
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 10558281 was registered on 31 Dec 2014.
Galaxystar Pharma Private Limited was incorporated on 17 Mar 2011.
The authorized share capital of Galaxystar Pharma Private Limited is ₹ 1.30 Cr and paid-up capital is ₹ 9.88 M.
Currently 2 directors are associated with Galaxystar Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Galaxystar Pharma Private Limited is 10/14 Sachin Society Mithagar Road, Mulund (East) India, Mumbai, Maharashtra, 400081.
The corporate identification number (CIN) of Galaxystar Pharma Private Limited is U51909MH2011PTC214896 and the company number is 214896 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2021, the revenue trend for Galaxystar Pharma Private Limited has risen by 27.43%.
The financial reports for the fiscal year 2021 indicates that The net worth of Galaxystar Pharma Private Limited has experienced an downturn of -2.33%.
The most recent Balance Sheet for Galaxystar Pharma Private Limited was filed with the ROC on 31 Mar 2022.
RK